Medibank Historical Cash Flow

MPL Stock

3.74 0.04 1.06%

Analysis of Medibank Private cash flow over time is an excellent tool to project Medibank Private future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 346.7 M or Depreciation of 93.9 M as it is a great indicator of Medibank Private ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Medibank Private latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medibank Private is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medibank Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Medibank balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medibank's non-liquid assets can be easily converted into cash.

Medibank Private Cash Flow Chart

At this time, Medibank Private's Change To Liabilities is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 4.4 M in 2024, whereas Dividends Paid is likely to drop slightly above 370.3 M in 2024.

Change To Inventory Free Cash Flow Dividends Paid Capital Expenditures

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Medibank Private to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Medibank Private operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from Medibank Private's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medibank Private current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024 (projected)
Capital Expenditures	41.9M	57.6M	29.7M
Dividends Paid	374.5M	426.9M	370.3M

Capital Expenditures Dividends Paid

Medibank Private cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Change To Account Receivables	Net Income	End Period Cash Flow	Investments	Begin Period Cash Flow	Change To Operating Activities	Change To Netincome	Change To Liabilities	Stock Based Compensation	Sale Purchase Of Stock	Net Borrowings
Change To Inventory		-0.09	-0.31	-0.89	-0.87	-0.59	-0.29	-0.23	-0.02	0.7	0.18	0.05	0.39	0.51	0.51	-0.15	-0.13	0.81	0.35
Change In Cash	-0.09		-0.44	0.37	-0.06	-0.3	-0.67	0.0	0.64	-0.37	0.76	0.4	0.32	-0.01	0.33	0.26	-0.45	0.09	0.34
Free Cash Flow	-0.31	-0.44		0.23	0.54	0.85	0.62	0.13	-0.33	-0.09	-0.25	-0.52	-0.5	0.27	-0.1	-0.46	0.35	-0.33	-0.38
Change In Working Capital	-0.89	0.37	0.23		0.81	0.46	0.04	0.25	0.33	-0.81	0.07	-0.02	-0.25	-0.53	-0.4	0.29	-0.09	-0.79	-0.16
Depreciation	-0.87	-0.06	0.54	0.81		0.7	0.5	0.46	-0.15	-0.63	-0.1	-0.15	-0.35	-0.31	-0.42	-0.03	0.23	-0.88	-0.54
Other Non Cash Items	-0.59	-0.3	0.85	0.46	0.7		0.62	0.35	-0.27	-0.51	-0.13	-0.46	-0.31	0.18	-0.03	-0.23	0.12	-0.43	-0.31
Dividends Paid	-0.29	-0.67	0.62	0.04	0.5	0.62		0.42	-0.73	-0.05	-0.34	0.01	-0.47	-0.01	-0.25	-0.46	0.39	-0.41	-0.37
Capital Expenditures	-0.23	0.0	0.13	0.25	0.46	0.35	0.42		-0.38	-0.53	0.32	-0.01	0.34	-0.01	0.15	0.29	0.03	-0.36	-0.39
Change To Account Receivables	-0.02	0.64	-0.33	0.33	-0.15	-0.27	-0.73	-0.38		-0.26	0.38	-0.03	0.31	-0.06	0.18	0.3	-0.53	0.09	0.48
Net Income	0.7	-0.37	-0.09	-0.81	-0.63	-0.51	-0.05	-0.53	-0.26		-0.31	0.02	-0.12	0.3	0.03	-0.42	0.44	0.51	-0.06
End Period Cash Flow	0.18	0.76	-0.25	0.07	-0.1	-0.13	-0.34	0.32	0.38	-0.31		0.35	0.59	0.4	0.61	0.04	-0.51	0.21	0.37
Investments	0.05	0.4	-0.52	-0.02	-0.15	-0.46	0.01	-0.01	-0.03	0.02	0.35		-0.14	-0.31	-0.08	-0.15	-0.19	0.05	0.4
Begin Period Cash Flow	0.39	0.32	-0.5	-0.25	-0.35	-0.31	-0.47	0.34	0.31	-0.12	0.59	-0.14		0.4	0.6	0.43	-0.38	0.34	0.14
Change To Operating Activities	0.51	-0.01	0.27	-0.53	-0.31	0.18	-0.01	-0.01	-0.06	0.3	0.4	-0.31	0.4		0.8	-0.5	-0.09	0.59	0.06
Change To Netincome	0.51	0.33	-0.1	-0.4	-0.42	-0.03	-0.25	0.15	0.18	0.03	0.61	-0.08	0.6	0.8		-0.15	-0.32	0.69	0.26
Change To Liabilities	-0.15	0.26	-0.46	0.29	-0.03	-0.23	-0.46	0.29	0.3	-0.42	0.04	-0.15	0.43	-0.5	-0.15		-0.19	-0.12	-0.05
Stock Based Compensation	-0.13	-0.45	0.35	-0.09	0.23	0.12	0.39	0.03	-0.53	0.44	-0.51	-0.19	-0.38	-0.09	-0.32	-0.19		-0.26	-0.78
Sale Purchase Of Stock	0.81	0.09	-0.33	-0.79	-0.88	-0.43	-0.41	-0.36	0.09	0.51	0.21	0.05	0.34	0.59	0.69	-0.12	-0.26		0.46
Net Borrowings	0.35	0.34	-0.38	-0.16	-0.54	-0.31	-0.37	-0.39	0.48	-0.06	0.37	0.4	0.14	0.06	0.26	-0.05	-0.78	0.46

Click cells to compare fundamentals

Medibank Private Account Relationship Matchups

Medibank Private cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change In Cash	214.9M	(199.7M)	(75M)	(176.1M)	270.4M	283.9M
Free Cash Flow	543.1M	447.1M	913.4M	142.6M	810.9M	467.2M
Change In Working Capital	9.9M	(8.8M)	(11.1M)	(22M)	330.2M	346.7M
Other Cashflows From Financing Activities	(33.3M)	(37M)	(38.8M)	(39.7M)	(51.6M)	(54.2M)
Depreciation	49.2M	45.1M	41.2M	40.7M	89.4M	93.9M
Other Non Cash Items	208.2M	(4.1M)	513.4M	(367.3M)	445M	467.3M
Dividends Paid	429.6M	333.2M	358M	374.5M	426.9M	370.3M
Capital Expenditures	9.8M	29.3M	35.1M	41.9M	57.6M	29.7M
Total Cash From Operating Activities	572.4M	482.2M	948.5M	184.5M	868.5M	496.9M
Change To Account Receivables	6.3M	9.9M	(8.8M)	(11.1M)	(22M)	10.4M
Net Income	315M	441.2M	393.9M	511.1M	3.9M	3.7M
Total Cash From Financing Activities	(466.7M)	(375.8M)	(399.9M)	(419.1M)	(487.3M)	(511.7M)
End Period Cash Flow	871.4M	671.7M	596.7M	420.6M	691M	494.9M
Investments	110.7M	(284.1M)	(602.7M)	58.5M	(110.8M)	(116.3M)
Begin Period Cash Flow	656.5M	871.4M	671.7M	596.7M	420.6M	489.6M
Total Cashflows From Investing Activities	109.2M	(306.1M)	(623.6M)	58.5M	52.7M	55.3M
Change To Operating Activities	228.1M	71.4M	282.8M	(180.5M)	(207.6M)	(197.2M)
Other Cashflows From Investing Activities	27.8M	13.1M	14.2M	100.4M	115.5M	121.2M
Change To Netincome	13.8M	(111M)	30.2M	(126.9M)	(145.9M)	(153.2M)
Change To Liabilities	(157.6M)	31.3M	14.5M	99.2M	89.3M	93.7M
Stock Based Compensation	1.6M	5.2M	5.9M	6.7M	3.3M	4.4M
Sale Purchase Of Stock	(3.8M)	(5.6M)	(3.1M)	(4.9M)	(7.5M)	(7.1M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medibank Stock Analysis

When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC